126 related articles for article (PubMed ID: 16542152)
1. Endotoxin-like properties of a rhamnolipid exotoxin from Burkholderia (Pseudomonas) plantarii: immune cell stimulation and biophysical characterization.
Andrä J; Rademann J; Howe J; Koch MH; Heine H; Zähringer U; Brandenburg K
Biol Chem; 2006 Mar; 387(3):301-10. PubMed ID: 16542152
[TBL] [Abstract][Full Text] [Related]
2. Biophysical characterization of synthetic rhamnolipids.
Howe J; Bauer J; Andrä J; Schromm AB; Ernst M; Rössle M; Zähringer U; Rademann J; Brandenburg K
FEBS J; 2006 Nov; 273(22):5101-12. PubMed ID: 17059466
[TBL] [Abstract][Full Text] [Related]
3. Purification and characterization of a cytotoxic exolipid of Burkholderia pseudomallei.
Häussler S; Nimtz M; Domke T; Wray V; Steinmetz I
Infect Immun; 1998 Apr; 66(4):1588-93. PubMed ID: 9529085
[TBL] [Abstract][Full Text] [Related]
4. Endotoxin evaluation of eleven lipopolysaccharides by whole blood assay does not always correlate with Limulus amebocyte lysate assay.
Dehus O; Hartung T; Hermann C
J Endotoxin Res; 2006; 12(3):171-80. PubMed ID: 16719988
[TBL] [Abstract][Full Text] [Related]
5. Effects of rhamnolipid-biosurfactant on cell surface of Pseudomonas aeruginosa.
Sotirova A; Spasova D; Vasileva-Tonkova E; Galabova D
Microbiol Res; 2009; 164(3):297-303. PubMed ID: 17416508
[TBL] [Abstract][Full Text] [Related]
6. lux-marked Pseudomonas aeruginosa lipopolysaccharide production in the presence of rhamnolipid.
Chen G; Zhu H
Colloids Surf B Biointerfaces; 2005 Mar; 41(1):43-8. PubMed ID: 15698755
[TBL] [Abstract][Full Text] [Related]
7. Chemical structure and in vitro antitumor activity of rhamnolipids from Pseudomonas aeruginosa BN10.
Christova N; Tuleva B; Kril A; Georgieva M; Konstantinov S; Terziyski I; Nikolova B; Stoineva I
Appl Biochem Biotechnol; 2013 Jun; 170(3):676-89. PubMed ID: 23604971
[TBL] [Abstract][Full Text] [Related]
8. Complement activating property of the protein-rich endotoxin (OEP) of Pseudomonas aeruginosa. II. Complement activating property of the lipopolysaccharide portion and the inhibition by polymyxin B.
Inada K
Jpn J Exp Med; 1980 Apr; 50(2):107-15. PubMed ID: 6256561
[TBL] [Abstract][Full Text] [Related]
9. Rhamnolipid (RL) from Pseudomonas aeruginosa OBP1: a novel chemotaxis and antibacterial agent.
Bharali P; Saikia JP; Ray A; Konwar BK
Colloids Surf B Biointerfaces; 2013 Mar; 103():502-9. PubMed ID: 23261573
[TBL] [Abstract][Full Text] [Related]
10. Biophysical characterization of lipopolysaccharide and lipid A inactivation by lactoferrin.
Brandenburg K; Jürgens G; Müller M; Fukuoka S; Koch MH
Biol Chem; 2001 Aug; 382(8):1215-25. PubMed ID: 11592403
[TBL] [Abstract][Full Text] [Related]
11. Chemical structures and biological activities of rhamnolipids produced by Pseudomonas aeruginosa B189 isolated from milk factory waste.
Thanomsub B; Pumeechockchai W; Limtrakul A; Arunrattiyakorn P; Petchleelaha W; Nitoda T; Kanzaki H
Bioresour Technol; 2006 Dec; 97(18):2457-61. PubMed ID: 16697639
[TBL] [Abstract][Full Text] [Related]
12. CD14 impairs host defense against gram-negative sepsis caused by Burkholderia pseudomallei in mice.
Wiersinga WJ; de Vos AF; Wieland CW; Leendertse M; Roelofs JJ; van der Poll T
J Infect Dis; 2008 Nov; 198(9):1388-97. PubMed ID: 18855560
[TBL] [Abstract][Full Text] [Related]
13. Induction of tumor necrosis factor (TNF) and interleukin-1 (IL-1) by Pseudomonas aeruginosa and exotoxin A-induced suppression of lymphoproliferation and TNF, lymphotoxin, gamma interferon, and IL-1 production in human leukocytes.
Staugas RE; Harvey DP; Ferrante A; Nandoskar M; Allison AC
Infect Immun; 1992 Aug; 60(8):3162-8. PubMed ID: 1639487
[TBL] [Abstract][Full Text] [Related]
14. The physicochemistry of endotoxins in relation to bioactivity.
Gutsmann T; Schromm AB; Brandenburg K
Int J Med Microbiol; 2007 Sep; 297(5):341-52. PubMed ID: 17452014
[TBL] [Abstract][Full Text] [Related]
15. Rapid multiplex immunofluorescent assay to detect antibodies against Burkholderia pseudomallei and taxonomically closely related nonfermenters.
Iihara H; Niwa T; Shah MM; Nhung PH; Song SX; Hayashi M; Ohkusa K; Itoh Y; Makino S; Ezaki T
Jpn J Infect Dis; 2007 Jul; 60(4):230-4. PubMed ID: 17642542
[TBL] [Abstract][Full Text] [Related]
16. Toll-like receptors 2 and 4 mediate Abeta(1-42) activation of the innate immune response in a human monocytic cell line.
Udan ML; Ajit D; Crouse NR; Nichols MR
J Neurochem; 2008 Jan; 104(2):524-33. PubMed ID: 17986235
[TBL] [Abstract][Full Text] [Related]
17. Endotoxin tolerance attenuates LPS-induced TLR4 mobilization to lipid rafts: a condition reversed by PKC activation.
Cuschieri J; Billigren J; Maier RV
J Leukoc Biol; 2006 Dec; 80(6):1289-97. PubMed ID: 16959900
[TBL] [Abstract][Full Text] [Related]
18. Antimalarial artesunate protects sepsis model mice against heat-killed Escherichia coli challenge by decreasing TLR4, TLR9 mRNA expressions and transcription factor NF-kappa B activation.
Li B; Zhang R; Li J; Zhang L; Ding G; Luo P; He S; Dong Y; Jiang W; Lu Y; Cao H; Zheng J; Zhou H
Int Immunopharmacol; 2008 Mar; 8(3):379-89. PubMed ID: 18279792
[TBL] [Abstract][Full Text] [Related]
19. Toll-like receptor activity in recurrent aphthous ulceration.
Borra RC; de Mesquita Barros F; de Andrade Lotufo M; Villanova FE; Andrade PM
J Oral Pathol Med; 2009 Mar; 38(3):289-98. PubMed ID: 19267841
[TBL] [Abstract][Full Text] [Related]
20. Comparative study of interleukin-1beta expression by peripheral blood mononuclear cells and purified monocytes experimentally infected with Burkholderia pseudomallei and Burkholderia thailandensis.
Pongcharoen S; Niumsup PR; Butkhamchot P
Immunol Invest; 2008; 37(7):704-13. PubMed ID: 18821217
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
